JPWO2020043762A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020043762A5
JPWO2020043762A5 JP2021510859A JP2021510859A JPWO2020043762A5 JP WO2020043762 A5 JPWO2020043762 A5 JP WO2020043762A5 JP 2021510859 A JP2021510859 A JP 2021510859A JP 2021510859 A JP2021510859 A JP 2021510859A JP WO2020043762 A5 JPWO2020043762 A5 JP WO2020043762A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
patient
application
per
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021510859A
Other languages
English (en)
Japanese (ja)
Other versions
JP7420791B2 (ja
JP2021536454A (ja
JP2021536454A5 (https=
Publication date
Priority claimed from EP18191289.0A external-priority patent/EP3616693A1/en
Application filed filed Critical
Publication of JP2021536454A publication Critical patent/JP2021536454A/ja
Publication of JPWO2020043762A5 publication Critical patent/JPWO2020043762A5/ja
Publication of JP2021536454A5 publication Critical patent/JP2021536454A5/ja
Application granted granted Critical
Publication of JP7420791B2 publication Critical patent/JP7420791B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021510859A 2018-08-28 2019-08-28 ハイリスクヒトパピローマウイルス感染症の治療 Active JP7420791B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18191289.0A EP3616693A1 (en) 2018-08-28 2018-08-28 Therapy of high-risk human papillomavirus infections
EP18191289.0 2018-08-28
PCT/EP2019/072926 WO2020043762A1 (en) 2018-08-28 2019-08-28 Therapy of high-risk human papillomavirus infections

Publications (4)

Publication Number Publication Date
JP2021536454A JP2021536454A (ja) 2021-12-27
JPWO2020043762A5 true JPWO2020043762A5 (https=) 2022-08-10
JP2021536454A5 JP2021536454A5 (https=) 2022-08-10
JP7420791B2 JP7420791B2 (ja) 2024-01-23

Family

ID=63442535

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021510859A Active JP7420791B2 (ja) 2018-08-28 2019-08-28 ハイリスクヒトパピローマウイルス感染症の治療

Country Status (25)

Country Link
US (2) US20210299163A1 (https=)
EP (2) EP3616693A1 (https=)
JP (1) JP7420791B2 (https=)
CN (1) CN112584828A (https=)
AR (1) AR116027A1 (https=)
AU (1) AU2019332079B2 (https=)
BR (1) BR112021003360A2 (https=)
CA (1) CA3107691C (https=)
CL (1) CL2021000197A1 (https=)
EA (1) EA202190441A1 (https=)
ES (1) ES2958808T3 (https=)
GE (2) GEAP202215586A (https=)
HR (1) HRP20231470T1 (https=)
HU (1) HUE064691T2 (https=)
IL (1) IL281080B2 (https=)
MA (1) MA53482B1 (https=)
MD (1) MD3843715T2 (https=)
MX (1) MX2021002310A (https=)
PL (1) PL3843715T3 (https=)
RS (1) RS64916B1 (https=)
SM (1) SMT202300340T1 (https=)
TW (1) TWI827652B (https=)
UA (1) UA127632C2 (https=)
WO (1) WO2020043762A1 (https=)
ZA (1) ZA202100375B (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3875083A1 (en) * 2020-03-03 2021-09-08 Selo Medical GmbH Composition for use in a treatment of cervical cell abnormalities comprising selenite compound and acid

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2245301C2 (ru) 2000-05-10 2005-01-27 Окофарм Форшунгс-Унд Энтвиклюнгс-Гмбх Способ уменьшения площади поверхности диоксида кремния
AT412758B (de) 2000-06-05 2005-07-25 Vis Vitalis Lizenz & Handels Verwendung einer selenithältigen lösung zur behandlung viraler erkrankungen
AT412448B (de) 2001-02-13 2005-03-25 Vis Vitalis Lizenz & Handels Verwendung von selenhältigen präparaten
AT412703B (de) * 2001-12-04 2005-06-27 Vis Vitalis Lizenz & Handels Verwendung von selenithältigen präparaten zur topischen oder bukkalen anwendung
AT511159A1 (de) * 2011-02-16 2012-09-15 Selo Medical Gmbh Pharmazeutische zusammensetzungen enthaltend selenit- oder selenathältige verbindungen

Similar Documents

Publication Publication Date Title
JP2023002662A5 (https=)
JP6487534B2 (ja) 細菌性膣炎の治療に使用するためのセクニダゾール
JPH0739347B2 (ja) 硫酸化糖類の用途
US12357655B2 (en) Polyglutamic acid compositions and methods of using
JP3883867B2 (ja) モダフィニル及びそのd/l鏡像異性体の新規な使用
CN105342987A (zh) 一种凝胶及其制备方法和应用
JPWO2020043762A5 (https=)
US20080268022A1 (en) Mehtods for treating and preventing ailments caused by human papillomavirus
PERSELLIN et al. Fungal endocarditis following cardiac surgery
JP2021536454A5 (https=)
RU2237475C1 (ru) Комбинированный препарат для устранения симптомов простудных заболеваний и гриппа (варианты)
HRP20231470T1 (hr) Terapija za infekcije humanim papilomavirusom visokog rizika
CN112074291A (zh) 预防和治疗呼吸道疾病的组合物
RU2283133C1 (ru) Лечебное средство
ES2280150T3 (es) Asociacion de fluconazol-tinidazol para el tratamiento de infecciones vaginales, su composicion, proceso de preparacion y uso.
JP2007518797A5 (https=)
JPWO2020081839A5 (https=)
HRP20240374T1 (hr) Pripravak za uporabu u liječenju anomalija cervikalnih stanica koji sadrži spoj selenita i kiselinu
EP4106783B1 (en) Composition for the treatment of skin and mucous membrane diseases
JPH10175852A5 (https=)
CN104771384A (zh) 紫草素的医药用途
JPWO2021175877A5 (https=)
RU2249465C1 (ru) Способ лечения и профилактики иммунодефицитных состояний и заболеваний, связанных с бактериальной или вирусной агрессией
RU2254857C1 (ru) Способ лечения вагинального кандидоза
CN1199951C (zh) 扁桃酸环丙沙星盐、扁桃酸氧氟沙星盐及其制备工艺